Heidelberg Pharma AG/ DE000A11QVV0 /
- - | Chg. - | Volume | Bid09:02:12 | Ask09:02:12 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
3.71EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 84.07 mill.EUR | 0.00% | - |
Assets
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .4000 | .9000 | 2.1000 | 2.1000 | 1.3000 | ||||||
Intangible Assets | 1.3000 | 1.2000 | 4.4000 | 4.1000 | 3.1000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 1.9000 | 2.2000 | 12.8000 | 12.5000 | 12.8000 | ||||||
Inventories | 0.0000 | .2000 | .5000 | .3000 | .0800 | ||||||
Accounts Receivable | 5 | 0.0000 | .2000 | .3000 | .2000 | ||||||
Cash and Cash Equivalents | 3.4000 | 1.9000 | 3.4000 | 23.4000 | 8.9000 | ||||||
Current Assets | 10.1000 | 3.4000 | 8 | 25.2000 | 9.5000 | ||||||
Total Assets | 12 | 5.6000 | 20.8000 | 37.7000 | 22.3000 |
Liabilities
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 2.1000 | 2 | 1.4000 | .9000 | .2000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 0.0000 | 0.0000 | 10.5000 | 2.6000 | 2.6000 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 9 | 6.9000 | 25.3000 | 17.8000 | 7.3000 | ||||||
Share Capital | 3.4500 | 4.6000 | 5.4000 | 7.8250 | 7.8250 | ||||||
Total Equity | 3 | -1.3000 | -4.5000 | 19.9000 | 14.9000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 12 | 5.6000 | 20.8000 | 37.7000 | 22.3000 |
Income Statement
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 13 | 1.3000 | 11.7000 | 17.8000 | 19.1000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -12.9000 | -23.1000 | -13.4000 | -8.9000 | -5 | ||||||
Interest Income | .2000 | - | -.5000 | -.5000 | -.0800 | ||||||
Income Before Taxes | -12.7000 | -23.1000 | -13.9000 | -9.4000 | -5 | ||||||
Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -12.7000 | -23.1000 | -13.9000 | -9.4000 | -5 |
Per Share
Cash Flow
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -18.4000 | -19.2000 | -9 | -5.1000 | -14.5000 | ||||||
Cash Flow from Investing Activities | -.1000 | -.5000 | .6000 | -.2000 | -.2000 | ||||||
Cash Flow from Financing | 9.8000 | 18.2000 | 9.8000 | 25.3000 | -.2000 | ||||||
Decrease / Increase in Cash | -8.7000 | -1.5000 | 1.5000 | 19.9000 | -14.4000 | ||||||
Employees | 71 | 80 | 124 | 128 | 92 |